Table 2 Incidence of threshold retinopathy of prematurity in newborns treated with ketorolac and historic controls. Only those alive at discharged included in the analyses.
From: Treatment of Retinopathy of Prematurity with topical ketorolac tromethamine: a preliminary study
Historic Controls | Ketorolac | Relative Risk (95%CI) P-value | Â | |
|---|---|---|---|---|
n/N(%) | n/N(%) | Crude | Adjusted* | Â |
Threshold retinopathy of prematurity | 6/35 (17.1) | 1/43 (2.3) | 0.14 (0.00 to 0.80) 0.041** | 0.12 (0.02 to 0.92) 0.04 |